胰腺图像挖掘:影像组学的系统综述
该系统综述检索MEDLINE数据库,纳入72项研究共8863名受试者,评估影像组学在胰腺疾病中的应用。主要应用为局灶性胰腺病变的鉴别诊断、胰腺疾病分类及预后或治疗反应预测;组学质量评分中位数为28%(四分位距22%–36%),与提取特征数量(r=0.52,p<0.001)和样本量(r=0.34,p=0.003)显著相关。作者结论认为胰腺影像组学是有前景的定量影像生物标志物,但在常规临床实践前需标准化图像采集协议和图像预处理。
要点
- 二阶纹理特征在胰腺疾病鉴别诊断中最有用,相关研究均发现统计学显著特征。
- 滤波图像特征在胰腺疾病分类和预测中最有用,相关研究均发现统计学显著特征。
- 组学质量评分中位数28%(四分位距22%–36%),与特征数量和样本量显著相关。
核心结论
- 胰腺影像组学有望成为局灶性胰腺病变和胰腺弥漫性改变的定量影像生物标志物。
- 影像组学特征的有用性可能因应用目的而异。
- 在考虑将胰腺影像组学用于常规临床实践之前,需标准化图像采集协议和图像预处理。
研究设计与样本
- 系统综述,检索MEDLINE数据库,纳入研究人类胰腺疾病影像组学应用的文献,共72项研究、8863名受试者。
- 纳入研究中66项探讨局灶性胰腺病变(胰腺癌、癌前病变或良性病变),4项探讨胰腺炎,2项探讨糖尿病。
- 对每项纳入研究计算影像组学质量评分。
诊断标准与关键数值
- 影像组学主要应用包括:各种局灶性胰腺病变之间的鉴别诊断(n=19)、胰腺疾病分类(n=23)、预后或治疗反应预测(n=30)。
- 二阶纹理特征对胰腺疾病鉴别诊断最有用,100%研究这些特征的研究发现了统计学显著特征。
- 滤波图像特征对胰腺疾病分类和胰腺疾病预测最有用,100%研究这些特征的研究发现了统计学显著特征。
- 纳入研究的影像组学质量评分中位数为28%,四分位距为22%至36%。
- 影像组学质量评分与提取的影像组学特征数量显著相关(r=0.52,p<0.001),与研究样本量显著相关(r=0.34,p=0.003)。
临床应用与阅片要点
- 作者结论认为胰腺影像组学是有前景的个性化医学工具,但常规临床实践前需标准化图像采集协议和图像预处理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To systematically review published studies on the use of radiomics of the pancreas.
METHODS: The search was conducted in the MEDLINE database. Human studies that investigated the applications of radiomics in diseases of the pancreas were included. The radiomics quality score was calculated for each included study.
RESULTS: A total of 72 studies encompassing 8863 participants were included. Of them, 66 investigated focal pancreatic lesions (pancreatic cancer, precancerous lesions, or benign lesions); 4, pancreatitis; and 2, diabetes mellitus. The principal applications of radiomics were differential diagnosis between various types of focal pancreatic lesions (n = 19), classification of pancreatic diseases (n = 23), and prediction of prognosis or treatment response (n = 30). Second-order texture features were most useful for the purpose of differential diagnosis of diseases of the pancreas (with 100% of studies investigating them found a statistically significant feature), whereas filtered image features were most useful for the purpose of classification of diseases of the pancreas and prediction of diseases of the pancreas (with 100% of studies investigating them found a statistically significant feature). The median radiomics quality score of the included studies was 28%, with the interquartile range of 22% to 36%. The radiomics quality score was significantly correlated with the number of extracted radiomics features (r = 0.52, p < 0.001) and the study sample size (r = 0.34, p = 0.003).
CONCLUSIONS: Radiomics of the pancreas holds promise as a quantitative imaging biomarker of both focal pancreatic lesions and diffuse changes of the pancreas. The usefulness of radiomics features may vary depending on the purpose of their application. Standardisation of image acquisition protocols and image pre-processing is warranted prior to considering the use of radiomics of the pancreas in routine clinical practice.
KEY POINTS: • Methodologically sound studies on radiomics of the pancreas are characterised by a large sample size and a large number of extracted features. • Optimisation of the radiomics pipeline will increase the clinical utility of mineable pancreas imaging data. • Radiomics of the pancreas is a promising personalised medicine tool in diseases of the pancreas.
引用
- Abunahel BM, Pontre B, Kumar H, et al. Pancreas image mining: a systematic review of radiomics. Eur Radiol. 2020. PMID: 33151391. doi:10.1007/s00330-020-07376-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。